Borrowing CAR-T tool from cancer therapy, lupus patients go into remission
September 15, 20221 min read118 words
Published: September 15, 2022  |  1 min read118 words
heumatology — the study of immune-system-driven diseases of the bones, joints, muscles, and in-betweens — has inherited plenty of hand-me-downs from cancer research. For example, there are ways of squelching an immune system in order to shrink certain kinds of cancerous tumors. A...
Borrowing CAR-T tool from cancer therapy, lupus patients go into remission Read more

No article scores yet.

There are no critic or public scores for this article yet.
Great Context1
critic reviews: 0
public reviews: 1
No reviews
img-contested
N/A
critic score
2 reviews
img-trusted
86%
public score
36 reviews
img-contested
N/A
critic score
0 reviews
img-contested
N/A
public score
2 reviews

CRITIC REVIEWS

There don't seem to be any reviews yet.

PUBLIC REVIEWS

Great Context
September 29, 2022
A treatment borrowed from the fight against cancer seems to be also effective against various diseases that affect the immune system, such as the one depicted in the article, lupus. The author quotes some doctors and cites the progress that’s being made by this discovery, as well as what else it could mean for future healthcare.
September 29, 2022
Is this helpful?